1081 related articles for article (PubMed ID: 27668386)
1. Glioblastoma: Overview of Disease and Treatment.
Davis ME
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S2-8. PubMed ID: 27668386
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy.
Saria MG; Kesari S
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S9-S13. PubMed ID: 27668388
[TBL] [Abstract][Full Text] [Related]
3. The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.
Burri SH; Gondi V; Brown PD; Mehta MP
Am J Clin Oncol; 2018 Feb; 41(2):191-196. PubMed ID: 28832384
[TBL] [Abstract][Full Text] [Related]
4. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
Kesari S; Ram Z;
CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
[TBL] [Abstract][Full Text] [Related]
5. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
6. Laser interstitial thermal therapy for newly diagnosed and recurrent glioblastoma.
Thomas JG; Rao G; Kew Y; Prabhu SS
Neurosurg Focus; 2016 Oct; 41(4):E12. PubMed ID: 27690657
[TBL] [Abstract][Full Text] [Related]
7. Regorafenib in glioblastoma recurrence: A case report.
Detti B; Scoccianti S; Lucidi S; Maragna V; Teriaca MA; Ganovelli M; Desideri I; Lorenzetti V; Scoccimarro E; Greto D; Livi L
Cancer Treat Res Commun; 2021; 26():100263. PubMed ID: 33338858
[TBL] [Abstract][Full Text] [Related]
8. Treating recurrent glioblastoma: an update.
Kamiya-Matsuoka C; Gilbert MR
CNS Oncol; 2015; 4(2):91-104. PubMed ID: 25768333
[TBL] [Abstract][Full Text] [Related]
9. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
Schwartz MA; Onuselogu L
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
[TBL] [Abstract][Full Text] [Related]
10. Tumor Treating Fields in the Management of Patients with Malignant Gliomas.
Ghiaseddin AP; Shin D; Melnick K; Tran DD
Curr Treat Options Oncol; 2020 Jul; 21(9):76. PubMed ID: 32734509
[TBL] [Abstract][Full Text] [Related]
11. Progress and prospect in tumor treating fields treatment of glioblastoma.
Liu S; Shi W; Zhao Q; Zheng Z; Liu Z; Meng L; Dong L; Jiang X
Biomed Pharmacother; 2021 Sep; 141():111810. PubMed ID: 34214730
[TBL] [Abstract][Full Text] [Related]
12. A roundtable discussion on the clinical challenges and options for the treatment of glioblastoma: introducing a novel modality, TTFields.
Butowski N; Wong ET; Mehta MP; Wilson LK
Semin Oncol; 2013 Dec; 40(6):S2-4. PubMed ID: 24331200
[TBL] [Abstract][Full Text] [Related]
13. Salvage therapy for recurrent glioblastoma multiforme: a multimodal approach combining fluorescence-guided resurgery, interstitial irradiation, and chemotherapy.
Archavlis E; Tselis N; Birn G; Ulrich P; Zamboglou N
Neurol Res; 2014 Dec; 36(12):1047-55. PubMed ID: 24852696
[TBL] [Abstract][Full Text] [Related]
14. Recurrent glioblastoma multiforme: a review of natural history and management options.
Hou LC; Veeravagu A; Hsu AR; Tse VC
Neurosurg Focus; 2006 Apr; 20(4):E5. PubMed ID: 16709036
[TBL] [Abstract][Full Text] [Related]
15. What next for newly diagnosed glioblastoma?
Domingo-Musibay E; Galanis E
Future Oncol; 2015; 11(24):3273-83. PubMed ID: 26558493
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors.
Schäfer N; Gielen GH; Rauschenbach L; Kebir S; Till A; Reinartz R; Simon M; Niehusmann P; Kleinschnitz C; Herrlinger U; Pietsch T; Scheffler B; Glas M
J Transl Med; 2019 Mar; 17(1):96. PubMed ID: 30894200
[TBL] [Abstract][Full Text] [Related]
17. [Current status and prospect in the treatment of glioblastoma].
Jiang HH; Lin S
Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):70-74. PubMed ID: 31902174
[TBL] [Abstract][Full Text] [Related]
18. Tumor treating fields therapy is feasible and safe in a 3-year-old patient with diffuse midline glioma H3K27M - a case report.
Gött H; Kiez S; Dohmen H; Kolodziej M; Stein M
Childs Nerv Syst; 2022 Sep; 38(9):1791-1796. PubMed ID: 35181800
[TBL] [Abstract][Full Text] [Related]
19. Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial.
Toms SA; Kim CY; Nicholas G; Ram Z
J Neurooncol; 2019 Jan; 141(2):467-473. PubMed ID: 30506499
[TBL] [Abstract][Full Text] [Related]
20. Molecularly targeted therapies for recurrent glioblastoma: current and future targets.
Lau D; Magill ST; Aghi MK
Neurosurg Focus; 2014 Dec; 37(6):E15. PubMed ID: 25434384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
